Juan Qin, PhD
@juanqinmed
Researcher in CardioOncology @Moslehi Lab/UCSF
ID: 1301724552003641350
04-09-2020 03:31:40
22 Tweet
137 Followers
214 Following
Role of #CardiacImaging in the Diagnosis of Immune Checkpoints Inhibitors #Myocarditis: bit.ly/2TaVCU4 #CardioOncology #oncology #cardiotwitter DrJE-Salem Frontiers - Oncology
We are honored to have my mentor Prof. Moslehi Javid Moslehi as a main speaker in Annual Cardio-oncology Symposium- International Cardio-Oncology Society China Chapter Opening. Excited to see this historic moment and meet the top cardio-oncologists in China this weekend!
A+ job by Vanderbilt #CardioOnc fellow Matt Fleming & Ling Xiao on this Circulation Research review. Yes! Vascular disease is a bit part of #CardioOnc! Thanks to Naomi Hamburg 2 include vascular #CardioOnc as part of the recent compendium! Aaron W. Aday AHA Research Umberto Campia Vanderbilt Health
Looking forward to have Laura Cappelli from Johns Hopkins Medicine as VPOINT speaker this week! Erin D. Michos, M.D. BalkoResearchLab Leslie Crofford Jeff Rathmell Rachel Bonami Christine Lovly, MD, PhD Philip Lab Kimryn Rathmell Immunoengineering Lab Alan Baik Lawrence Fong MD UCSF Helen Diller Family Comprehensive Cancer Ctr UCSF Bakar ImmunoX Initiative medsites.vumc.org/vpoint/home
Just published in #EuropeanHeartJournal doi.org/10.1093/eurhea… Anti-PD1 immune checkpoint inhibitor therapy induces an immune-mediated disruption of cardiac integrity that can be prevented by blockade of tumour necrosis factor alpha. Congrats to Lars Michel
It may be holiday week but the UC San Francisco #CardioOnc #CardioImmuno conference continues! Dr. YC Chen (Tapei Medical Univ): Myocarditis after sequential PD-1-PD-L1 Rx. Could initial anti-PD1 Rx induce PD-L1 in the heart (as a potential mechanism)? Sean M Wu, MD PhD Han Zhu Lorenz Lehmann
Looking forward to A+ #CardioOnc fellow & physician-scientist Matthew Fleming presentation tomorrow! Matt has been a star! International Cardio-Oncology Society Juan Qin, PhD Tochi Okwuosa #GlobalHealth #CardioOnc Aarti Asnani Pharmacyclics, an AbbVie Company AstraZeneca Patrick Hu Vanderbilt PSTP/Harrison Society Vanderbilt Cardiology Fellowship wondrmedical.net/ch/IC-OS/event…
Looking for a post-doctoral position? Dr. Zian Tseng at UC San Francisco leads the Postmortem Systematic Investigation of Sudden Cardiac Death (POST SCD) project. Great for our #CardioOnc group to collaborate w/ him! #EPeeps AHA Research NIH NHLBI Greg Marcus ziantsenglab.ucsf.edu/join-our-team
Research Opportunities for post-doctoral fellows and research assistants at the Moslehi Lab and Section of Cardio-Oncology & Immunology at UC San Francisco! Email me if interested! #CardioOnc #CardioImmunology #DrugDiscovery UCSF Cardiology UCSF Helen Diller Family Comprehensive Cancer Ctr UCSF Bakar ImmunoX Initiative UCSF School of Medicine
UCSF Section of Cardio-Oncology & Immunology Clinical Conference. Research opportunities in HHT by Mandar Aras, MD, PhD! VEGF inhibitors, IMiDs & Estrogen modulators all being used for Rx in HHT! We are continuing to define our section (& the field)! UC San Francisco #CardioOnc Alan Baik #HHT
So excited to share our work on immune checkpoint inhibitor toxicity in the heart! BalkoResearchLab Javid Moslehi
On the eve of #AHA22, excited 2 share our article in Science Translational Medicine which for the first time dissects mechanisms of sex differences in myocarditis. Work done w/ Chunru Lin & Liuqing Yang, A+ colleagues at MD Anderson Cancer Center! UCSF Cardiology UCSF Helen Diller Family Comprehensive Cancer Ctr science.org/doi/10.1126/sc…
Had an amazing time at the GCOS 2024! Thanks my mentor Javid Moslehi! Insightful talks Eric H Yang, MD Margaret Axelrod, MD, PhD Han Zhu , Evelyn J. Song reconnecting with old friends, meeting new collaborators, and so many new ideas sparked through interdisciplinary exchange! 💡 #GCOS2024